Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. (FHTX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 48 transactions totaling $8.3M, demonstrating a bullish sentiment with $1.5M in net insider flow. The most recent transaction on Sep 23, 2024 involved a sale of 857 shares valued at $8.7K.
FHTX Insider Activity Summary
Who Is Buying FHTX Stock?
No significant insider buying has been recorded for FHTX in the recent period.
Who Is Selling FHTX Stock?
No significant insider selling has been recorded for FHTX in the recent period.
Is Foghorn Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FHTX is bullish with an Insider Alignment Score of 59/100 and a net flow of $1.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
FHTX Frequently Asked Questions
Understanding FHTX Insider Activity
Insider trading at Foghorn Therapeutics Inc. (FHTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading FHTX stock, having executed 48 transactions in the past 90 days. The most active insider is Samuel Agresta (Executive), who has made 2 transactions totaling $3.7M.
Related Tools
Track Foghorn Therapeutics Inc. Insider Activity
Get notified when executives and directors at FHTX file new Form 4 transactions